Sunbing Xu

Hangzhou First People's Hospital

Papers

1

Total Citations

40

H-Index

1

About

Dr. Sunbing Xu is a leading surgical researcher whose work centers on advancing minimally invasive pancreatic surgery, with a particular focus on comparing robotic and laparoscopic techniques. His most influential contribution is a landmark 2018 meta-analysis that rigorously evaluated whether patients truly benefit more from robot-assisted distal pancreatectomy (RADP) than from conventional laparoscopic distal pancreatectomy (LDP). This study, which has garnered 40 citations, critically examined perioperative and economic outcomes, addressing a key controversy in the field by weighing the ergonomic advantages of robotic systems against their higher costs. Dr. Xu’s research provides essential, evidence-based guidance for surgeons and hospitals deciding between these two approaches, directly impacting clinical decision-making and patient care. His work is notable for its focus on both clinical efficacy and economic practicality, offering a balanced perspective that is rare in surgical innovation studies. By systematically analyzing these trade-offs, Dr. Xu has helped shape the conversation around the adoption of robotic surgery, making his contributions highly valuable to researchers and practitioners striving to optimize surgical outcomes in an era of rapidly evolving technology.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Do patients benefit more from robot assisted approach than conventional laparoscopic distal pancreatectomy? A meta-analysis of perioperative and economic outcomes
40 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Hangzhou First People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago